СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
Aim: To determine frequency of tumors with immunohistochemical markers of cancer stem cells (CSC) CD44+/CD24− in patients with breast cancer (BC) of different molecular subtype and to evaluate their prognostic value. Object: Surgical material of 132 patients with BC stage I–II, age from 23 to 75 yea...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2015 |
| Main Authors: | Chekhun, S.V., Zadvorny, T.V., Tymovska, Yu.O., Anikusko, M.F., Novak, O.E., Polishchuk, L.Z. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2015
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145447 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes / S.V. Chekhun, T.V. Zadvorny, Yu.O. Tymovska, M.F. Anikusko, O.E. Novak, L.Z. Polishchuk // Experimental Oncology. — 2015. — Т. 37, № 1. — С. 58-63. — Бібліогр.: 38 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)
by: Grybach, S.M., et al.
Published: (2018)
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017)
by: Yu. Lukianova, et al.
Published: (2017)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016)
by: Zavyalova, M., et al.
Published: (2016)
Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
by: Kropyvko, S.V., et al.
Published: (2019)
by: Kropyvko, S.V., et al.
Published: (2019)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)
by: S. Chekhun, et al.
Published: (2013)
EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
by: L. M. Kovalevska, et al.
Published: (2019)
by: L. M. Kovalevska, et al.
Published: (2019)
Stem cell therapy for hereditary breast cancer
by: Rassi, H.
Published: (2009)
by: Rassi, H.
Published: (2009)
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: D. E. Ryspayeva
Published: (2018)
by: D. E. Ryspayeva
Published: (2018)
Research of stem tumor cells subpopulation on models of breast cancer
by: T. S. Herheliuk, et al.
Published: (2022)
by: T. S. Herheliuk, et al.
Published: (2022)
Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
by: N. O. Verovkina, et al.
Published: (2017)
by: N. O. Verovkina, et al.
Published: (2017)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
by: Timovska, Yu., et al.
Published: (2011)
by: Timovska, Yu., et al.
Published: (2011)
Orally given chemo-endocrine therapy for patients with luminal Her-2/neu negative metastasing breast cancer
by: Yu. O. Tymovska, et al.
Published: (2016)
by: Yu. O. Tymovska, et al.
Published: (2016)
Epigenetics in breast cancer
by: Atalay, C.
Published: (2013)
by: Atalay, C.
Published: (2013)
Epigenetics in breast cancer
by: C. Atalay
Published: (2013)
by: C. Atalay
Published: (2013)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
The use of proteomic technologies in breast cancer research
by: Mazur, M.G., et al.
Published: (2016)
by: Mazur, M.G., et al.
Published: (2016)
Breast cancer with diabetes insipidus
by: Dogan, M., et al.
Published: (2008)
by: Dogan, M., et al.
Published: (2008)
Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)
by: Zakhartseva, L.M., et al.
Published: (2009)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
by: L. A. Nalieskina, et al.
Published: (2017)
by: L. A. Nalieskina, et al.
Published: (2017)
Determination of immunity T-cell link state and content of cancer stem cells as criterion to estimate efficiency of preventive breast cancer therapy with cryopreserved fetal liver cells
by: A. M. Holtsev, et al.
Published: (2014)
by: A. M. Holtsev, et al.
Published: (2014)
Hereditary breast cancer: current state of problem
by: I. M. Motuziuk, et al.
Published: (2018)
by: I. M. Motuziuk, et al.
Published: (2018)
Relevance the issues of breast cancer etiology and pathogenesis
by: Ju. A. Vinnik, et al.
Published: (2017)
by: Ju. A. Vinnik, et al.
Published: (2017)
Staging, risk assessment and screening of breast cancer
by: B. Yalcin
Published: (2013)
by: B. Yalcin
Published: (2013)
Immune checkpoint blockade in breast cancer therapy
by: I. A. Gromakova, et al.
Published: (2020)
by: I. A. Gromakova, et al.
Published: (2020)
The features of reproductive function in women with breast cancer
by: S. E. Ragimzade
Published: (2016)
by: S. E. Ragimzade
Published: (2016)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Prospects of the use of molecular markers in cancer of ovaries
by: A. A. Mikhanovskij, et al.
Published: (2015)
by: A. A. Mikhanovskij, et al.
Published: (2015)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016)
by: Medviediev, O., et al.
Published: (2016)
Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
by: I. P. Nesina, et al.
Published: (2019)
by: I. P. Nesina, et al.
Published: (2019)
The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
by: Dumanskiy, Y.V., et al.
Published: (2023)
by: Dumanskiy, Y.V., et al.
Published: (2023)
Similar Items
-
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015) -
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017) -
Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018) -
The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
by: Yu. Lukianova, et al.
Published: (2017) -
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)